The startup specializes in the research and production of medical probiotics derived from advanced fermentation techniques and microorganism development. Their products aim to enhance patient recovery by providing targeted probiotic solutions for various health conditions.
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many individuals experience challenges related to mental and neurological health, including mood disorders, stress, sleep disturbances, and neurodegenerative conditions. Existing treatments may not fully address the underlying causes or may have undesirable side effects. There is a need for natural and effective interventions that can promote overall well-being by targeting the gut-brain axis.
Solution
Bened Biomedical develops and supplies scientifically-backed psychobiotic strains that improve mental and neurological health through modulation of the gut-brain axis. Their probiotic strains, derived from advanced fermentation techniques, produce beneficial compounds that influence neurotransmitter levels, reduce stress hormones, and promote a healthy gut microbiota. These strains are available for product licensing, custom formulation, and distribution support, enabling partners to create innovative supplements and functional foods that address a range of health concerns, including mood, sleep, cognitive function, and physical performance. Bened Biomedical's strains are supported by clinical research and safety data, ensuring efficacy and consumer confidence.
Target Audience
Bened Biomedical's primary customers are pharmaceutical companies, nutraceutical manufacturers, and functional food producers seeking innovative, scientifically-validated probiotic strains to incorporate into their product lines.
Features
- PS128: Shown in clinical studies to regulate dopamine and serotonin, reduce stress, and improve mood, sleep, and motor control.
- PS23/HT-PS23: Demonstrated benefits for stress reduction, anxiety relief, muscle strength, and cognitive function, with HT-PS23 offering a shelf-stable postbiotic option.
- PS150/HT-PS150: Shown to improve sleep quality and reduce sleep latency, with HT-PS150 offering a shelf-stable postbiotic option.
- A17/K37: Designed to balance immune response and control allergies.
- K21: Supports lipid metabolism, weight management, and cholesterol control.
- CalmHere: A probiotic blend for pets that improves behavior, reduces anxiety and stress, and balances serotonin levels.
- Strains are available in both live and heat-killed (postbiotic) forms for diverse applications.
- Supported by extensive preclinical and clinical research, with numerous publications in peer-reviewed journals.
- GRAS (Generally Recognized as Safe) and QPS (Qualified Presumption of Safety) status, ensuring safety and regulatory compliance.